[go: up one dir, main page]

IL134111A0 - Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation - Google Patents

Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation

Info

Publication number
IL134111A0
IL134111A0 IL13411198A IL13411198A IL134111A0 IL 134111 A0 IL134111 A0 IL 134111A0 IL 13411198 A IL13411198 A IL 13411198A IL 13411198 A IL13411198 A IL 13411198A IL 134111 A0 IL134111 A0 IL 134111A0
Authority
IL
Israel
Prior art keywords
compounds
preparation
compositions containing
anovel
triazolo
Prior art date
Application number
IL13411198A
Other languages
English (en)
Original Assignee
Astra Pharmaceuticals Ltd Astr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceuticals Ltd Astr filed Critical Astra Pharmaceuticals Ltd Astr
Publication of IL134111A0 publication Critical patent/IL134111A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
IL13411198A 1997-07-22 1998-07-15 Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation IL134111A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
PCT/SE1998/001394 WO1999005144A1 (fr) 1997-07-22 1998-07-15 Nouveaux composes

Publications (1)

Publication Number Publication Date
IL134111A0 true IL134111A0 (en) 2001-04-30

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13411198A IL134111A0 (en) 1997-07-22 1998-07-15 Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation

Country Status (21)

Country Link
US (1) US6166022A (fr)
EP (1) EP0998475B1 (fr)
JP (1) JP2001510843A (fr)
KR (1) KR20010022084A (fr)
CN (1) CN1270591A (fr)
AT (1) ATE216390T1 (fr)
AU (1) AU8370798A (fr)
BR (1) BR9811028A (fr)
CA (1) CA2296426A1 (fr)
DE (1) DE69804966T2 (fr)
EE (1) EE200000048A (fr)
HU (1) HUP0003826A3 (fr)
ID (1) ID25856A (fr)
IL (1) IL134111A0 (fr)
IS (1) IS5352A (fr)
NO (1) NO20000313L (fr)
PL (1) PL338181A1 (fr)
SE (1) SE9702774D0 (fr)
SK (1) SK188299A3 (fr)
TR (1) TR200000152T2 (fr)
WO (1) WO1999005144A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
BR9907934A (pt) * 1998-02-17 2000-10-24 Astrazeneca Uk Ltd Composto, composição farmacêutica, e, processo para a preparação do composto
ATE263146T1 (de) 1999-09-09 2004-04-15 Chirotech Technology Ltd Substituierte cyclopentene, verfahren zu deren herstellung un deren verwendung als chirale gerüste
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) * 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
JP4879745B2 (ja) 2003-10-03 2012-02-22 ポートラ ファーマシューティカルズ， インコーポレイテッド 置換イソキノリノン
PL1668002T3 (pl) 2003-10-03 2010-02-26 Portola Pharm Inc 2,4-diokso-3-chinazolinyloarylowe pochodne sulfonylomocznika
EP1685135B1 (fr) 2003-10-21 2010-05-26 Inspire Pharmaceuticals, Inc. COMPOSES TETRAHYDRO-FURO[3,4-d]DIOXOLE, ET COMPOSITIONS ET PROCEDE POUR INHIBER UNE AGREGATION PLAQUETTAIRE
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
AU2005292314B2 (en) 2004-09-29 2011-11-03 Portola Pharmaceuticals, Inc. Substituted 2H-1,3-benzoxazin-4(3H)-ones
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JPWO2007020935A1 (ja) * 2005-08-17 2009-02-26 小野薬品工業株式会社 Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
AR056762A1 (es) 2005-11-03 2007-10-24 Portola Pharm Inc (4 -(6-halo-7- substituidos -2,4- dioxo-1,4- dihidro-2h-quinazolin-3-il- fenil)-5- cloro- tiophen-2- il sulfonilureas y formas y metodos
US7566722B2 (en) * 2006-10-31 2009-07-28 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
WO2011133871A2 (fr) * 2010-04-22 2011-10-27 Alnylam Pharmaceuticals, Inc. Dérivés d'extrémité 5'
WO2011150205A2 (fr) * 2010-05-27 2011-12-01 Dr. Reddy's Laboratories Ltd. Hydroformylation asymétrique extrêmement sélective de la (+) ou (-)-lactame (1s,4r)- ou (1r,4s)-2-azabicyclo[2.2.1]hept-5-én-3-one
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
CA2154681A1 (fr) * 1993-02-03 1994-08-18 Mark David Erion Inhibiteurs de l'adenosine kinase renfermant des derives lyxofuranosyliques
TW427996B (en) * 1995-07-11 2001-04-01 Astra Pharma Prod Novel triazolopyrimidines and their use as medicaments

Also Published As

Publication number Publication date
IS5352A (is) 2000-01-19
EP0998475B1 (fr) 2002-04-17
JP2001510843A (ja) 2001-08-07
AU8370798A (en) 1999-02-16
WO1999005144A1 (fr) 1999-02-04
CA2296426A1 (fr) 1999-02-04
DE69804966D1 (de) 2002-05-23
HUP0003826A3 (en) 2001-11-28
TR200000152T2 (tr) 2000-07-21
US6166022A (en) 2000-12-26
SE9702774D0 (sv) 1997-07-22
ATE216390T1 (de) 2002-05-15
NO20000313L (no) 2000-03-22
PL338181A1 (en) 2000-10-09
KR20010022084A (ko) 2001-03-15
SK188299A3 (en) 2000-08-14
HUP0003826A2 (hu) 2001-04-28
CN1270591A (zh) 2000-10-18
NO20000313D0 (no) 2000-01-21
ID25856A (id) 2000-11-09
DE69804966T2 (de) 2002-11-07
EP0998475A1 (fr) 2000-05-10
BR9811028A (pt) 2000-08-01
EE200000048A (et) 2000-10-16

Similar Documents

Publication Publication Date Title
IL134111A0 (en) Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation
IL134112A0 (en) Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation
IL132153A0 (en) Novel compounds
IL122855A0 (en) 7H-pyrrolo [2,3-d] pyrimidine derivatives their preparation and pharmaceutical compositions containing them
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
MY121867A (en) Novel triazolo(4,5-d)pyrimidine compounds.
PL340836A1 (en) Novel compounds
HUT70505A (en) Pyrrolo[2,3-d]pyrimidine derivatives, pharmaceutical compositions containing them and process for preparing them
CA2316921A1 (fr) Composes azapolycycliques fusionnes avec un aryle
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
IL130538A0 (en) Pyrrolo ¬3,4-d¾pyrimidinone derivatives and their use as medicaments
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
SE9702563D0 (sv) Compounds
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
AU2002214467A1 (en) Novel compounds
CA2235967A1 (fr) Derives de diarylethylene metallocene, procedes de preparation et compositions pharmaceutiques contenant ces derives